Clearbridge Investments, LLC Biogen Inc. Transaction History

Clearbridge Investments, LLC

$123 Billion
Q3 2024

A detailed history of Clearbridge Investments, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 601,986 shares of BIIB stock, worth $88.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

601,986

Previous 1,468,822 59.02%

Holding current value

$88.2 Million

Previous $341 Million 65.73%

% of portfolio

0.1%

Previous 0.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$189.07 - $236.8 $164 Million - $205 Million	-866,836 Reduced 59.02%	601,986 $117 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $17.7 Million - $22 Million	-92,838 Reduced 5.94%	1,468,822 $341 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $24.9 Million - $31.5 Million	-117,642 Reduced 7.01%	1,561,660 $337 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $32 Million - $38.6 Million	-143,880 Reduced 7.89%	1,679,302 $435 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $1.14 Million - $1.28 Million	-4,482 Reduced 0.25%	1,823,182 $469 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $10.2 Million - $11.8 Million	-37,081 Reduced 1.99%	1,827,664 $521 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $15.2 Million - $17.3 Million	59,170 Added 3.28%	1,864,745 $518 Million
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $17.7 Million - $21.5 Million	-70,065 Reduced 3.74%	1,805,575 $500 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $17.8 Million - $24.6 Million	-91,570 Reduced 4.65%	1,875,640 $501 Million
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $102 Million - $121 Million	-543,782 Reduced 21.66%	1,967,210 $401 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $2.4 Million - $3.03 Million	-12,410 Reduced 0.49%	2,510,992 $529 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $188 Million - $242 Million	-840,525 Reduced 24.99%	2,523,402 $605 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $56.9 Million - $74.2 Million	-201,185 Reduced 5.64%	3,363,927 $952 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $105 Million - $168 Million	-403,932 Reduced 10.18%	3,565,112 $1.23 Billion
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $90 Million - $105 Million	370,371 Added 10.29%	3,969,044 $1.11 Billion
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $98.8 Million - $149 Million	-418,011 Reduced 10.41%	3,598,673 $881 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $16.9 Million - $19.6 Million	-63,962 Reduced 1.57%	4,016,684 $1.14 Billion
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $84.5 Million - $112 Million	-326,665 Reduced 7.41%	4,080,646 $1.09 Billion
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $196 Million - $249 Million	-730,787 Reduced 14.22%	4,407,311 $1.39 Billion
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $241 Million - $333 Million	-1,094,579 Reduced 17.56%	5,138,098 $1.51 Billion
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $10.1 Million - $11.3 Million	-46,421 Reduced 0.74%	6,232,677 $1.45 Billion
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $507 Million - $559 Million	-2,313,259 Reduced 26.92%	6,279,098 $0
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $29.8 Million - $46.6 Million	-137,488 Reduced 1.57%	8,592,357 $2.03 Billion
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $32.2 Million - $40.8 Million	-115,604 Reduced 1.31%	8,729,845 $2.63 Billion
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $201 Million - $262 Million	-683,638 Reduced 7.17%	8,845,449 $3.13 Billion
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $87.8 Million - $105 Million	340,828 Added 3.71%	9,529,087 $2.77 Billion
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $12.1 Million - $17.1 Million	46,608 Added 0.51%	9,188,259 $2.52 Billion
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $33.6 Million - $37.6 Million	-109,176 Reduced 1.18%	9,141,651 $2.91 Billion
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $12.1 Million - $14.2 Million	-43,073 Reduced 0.46%	9,250,827 $2.9 Billion
Q2 2017 Aug 14, 2017	BUY	N/A	9,293,900	9,293,900 $2.52 Billion

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Biogen Inc. Transaction History